Also known as Shuimu Fund is an equity private equity fund that focuses on the development, integration, and M&A investment opportunities of medical, technology, and new economic industries. Its investment team members include people from multinational investment banks, private equity and venture capital funds, and legal and accounting professionals.

The investors of Shuimu Fund are mainly family offices and institutional investors. In order to meet the asset allocation and return requirements of these institutional investors, Shuimu Fund will focus on looking for leading Chinese and foreign companies in the industries of concern, judge the ability of these companies to withstand risks and seize opportunities in the economic cycle and industry consolidation, and cooperate with Shuimu Fund’s investment The team’s connections, industry, business management and mergers and acquisitions experience and resources can invest significant funds in the selected companies at the appropriate time, allowing the companies to take advantage of capital leverage and sharp changes in financial efficiency to leave behind competitors, integrate the industrial structure, or Subvert the existing stakeholders in the industry, become the leader of the industry, or create a market space that is more conducive to its own development. In line with this investment strategy, Shuimu Foundation prefers to invest in companies in the growth stage. It usually takes board seats in the invested companies, actively helps the companies expand their business, and strives to exit in the mid-term and obtain generous returns.